Back

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Ventricular tachycardia 4 Radiotherapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

8 More presentations in this session

Presentation thumbnail
Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR
Associate Professor B. Dinov (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Cardiac tumors with life threatening arrhythmia, an eight year single centre experience
Doctor O. Kamel (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation
Doctor M. De Smet (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)
Doctor O. Tovia Brodie (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Initial experience with ablation of ventricular arrhythmias using a pulsed-field system
Doctor P. Stojadinovic (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular tachycardia 4

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Cardio-oncology challenges: radiation therapy in patients with non-transvenous cardiac implantable devices
thumbnail
Congress Presentation
Outcomes of subcutaneous implantable cardioverter defibrillators: UK tertiary centre experience
thumbnail
Congress Presentation
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: data from a multicenter experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources